{"address1": "Life Science & Technology Park", "address2": "Suite 520 1951 NW 7th Avenue", "city": "Miami", "state": "FL", "zip": "33136", "country": "United States", "phone": "844 470 2550", "website": "https://longeveron.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Longeveron Inc., a clinical stage biotechnology company, develops cellular therapies for aging-related and life-threatening conditions in the United States. Its lead investigational product is the LOMECEL-B, an allogeneic mesenchymal stem cell formulation sourced from the bone marrow of young and healthy adult donors which is in phase 1 clinical trial to treat hypoplastic left heart syndrome; completed phase 2a clinical trial to treat Alzheimer's disease, as well as in phase 2b clinical trial to treat aging frailty. The company was incorporated in 2014 and is headquartered in Miami, Florida.", "fullTimeEmployees": 25, "companyOfficers": [{"maxAge": 1, "name": "Dr. Joshua Michael Hare FACC, M.D.", "age": 61, "title": "Co-Founder, Chief Science Officer & Chairman", "yearBorn": 1963, "fiscalYear": 2024, "totalPay": 600622, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Mohamed Wa'el Ahmed Hashad M.B.A.", "age": 62, "title": "CEO & Director", "yearBorn": 1962, "fiscalYear": 2024, "totalPay": 1012339, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Lisa A. Locklear M.B.A.", "age": 62, "title": "CFO, Executive VP & Treasurer", "yearBorn": 1962, "fiscalYear": 2024, "totalPay": 653391, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Paul T. Lehr J.D.", "age": 56, "title": "General Counsel & Secretary", "yearBorn": 1968, "fiscalYear": 2024, "totalPay": 748514, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Devin  Blass", "age": 38, "title": "CTO & Senior VP of Chemistry, Manufacturing, and Controls", "yearBorn": 1986, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Nataliya  Agafonova M.D.", "age": 54, "title": "Chief Medical Officer", "yearBorn": 1970, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Lisa  McClain-Moss", "age": 53, "title": "Vice President of Manufacturing", "yearBorn": 1971, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Brian G Rash Ph.D.", "title": "VP of Research & Discovery", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Heather  Zhou", "title": "VP & Corporate Controller", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 1.55, "open": 1.58, "dayLow": 1.49, "dayHigh": 1.621, "regularMarketPreviousClose": 1.55, "regularMarketOpen": 1.58, "regularMarketDayLow": 1.49, "regularMarketDayHigh": 1.621, "payoutRatio": 0.0, "beta": 0.363, "forwardPE": -0.98039216, "volume": 133293, "regularMarketVolume": 133293, "averageVolume": 298298, "averageVolume10days": 194350, "averageDailyVolume10Day": 194350, "bid": 1.48, "ask": 1.52, "bidSize": 1, "askSize": 1, "marketCap": 22391850, "fiftyTwoWeekLow": 0.771, "fiftyTwoWeekHigh": 6.4, "priceToSalesTrailing12Months": 9.361141, "fiftyDayAverage": 1.5924, "twoHundredDayAverage": 2.06485, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 4606854, "profitMargins": 0.0, "floatShares": 12621841, "sharesOutstanding": 13473900, "sharesShort": 736838, "sharesShortPriorMonth": 518880, "sharesShortPreviousMonthDate": 1739491200, "dateShortInterest": 1741910400, "sharesPercentSharesOut": 0.0494, "heldPercentInsiders": 0.0704, "heldPercentInstitutions": 0.08643, "shortRatio": 1.52, "shortPercentOfFloat": 0.0584, "impliedSharesOutstanding": 14927900, "bookValue": 1.47, "priceToBook": 1.0204082, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1735603200, "netIncomeToCommon": -24623000, "trailingEps": -2.62, "forwardEps": -1.53, "lastSplitFactor": "1:10", "lastSplitDate": 1711497600, "enterpriseToRevenue": 1.926, "enterpriseToEbitda": -0.296, "52WeekChange": -0.39999998, "SandP52WeekChange": 0.08089435, "quoteType": "EQUITY", "currentPrice": 1.5, "targetHighPrice": 10.0, "targetLowPrice": 6.0, "targetMeanPrice": 8.875, "targetMedianPrice": 9.75, "recommendationMean": 2.0, "recommendationKey": "buy", "numberOfAnalystOpinions": 4, "totalCash": 19232000, "totalCashPerShare": 1.288, "ebitda": -15564000, "totalDebt": 1447000, "quickRatio": 7.481, "currentRatio": 7.6, "totalRevenue": 2392000, "debtToEquity": 6.611, "revenuePerShare": 0.254, "returnOnAssets": -0.54874, "returnOnEquity": -1.1158999, "grossProfits": 1884000, "freeCashflow": -9274250, "operatingCashflow": -13868000, "revenueGrowth": 8.571, "grossMargins": 0.78763, "ebitdaMargins": 0.0, "operatingMargins": -7.0995, "financialCurrency": "USD", "symbol": "LGVN", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1613140200000, "preMarketChange": 0.00999999, "preMarketChangePercent": 0.66666603, "shortName": "Longeveron Inc.", "longName": "Longeveron Inc.", "corporateActions": [], "preMarketTime": 1743581346, "regularMarketTime": 1743537602, "exchange": "NCM", "messageBoardId": "finmb_410711455", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "regularMarketChangePercent": -3.2258034, "regularMarketPrice": 1.5, "cryptoTradeable": false, "marketState": "PRE", "preMarketPrice": 1.51, "regularMarketChange": -0.049999952, "regularMarketDayRange": "1.49 - 1.621", "fullExchangeName": "NasdaqCM", "averageDailyVolume3Month": 298298, "fiftyTwoWeekLowChange": 0.729, "fiftyTwoWeekLowChangePercent": 0.9455252, "fiftyTwoWeekRange": "0.771 - 6.4", "fiftyTwoWeekHighChange": -4.9, "fiftyTwoWeekHighChangePercent": -0.765625, "fiftyTwoWeekChangePercent": -39.999996, "earningsTimestampStart": 1620989940, "earningsTimestampEnd": 1620989940, "epsTrailingTwelveMonths": -2.62, "epsForward": -1.53, "fiftyDayAverageChange": -0.092399955, "fiftyDayAverageChangePercent": -0.058025595, "twoHundredDayAverageChange": -0.5648501, "twoHundredDayAverageChangePercent": -0.273555, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "ipoExpectedDate": "2021-02-12", "prevName": "Longeveron LLC", "nameChangeDate": "2025-04-01", "averageAnalystRating": "2.0 - Buy", "displayName": "Longeveron", "trailingPegRatio": null}